Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4961)
All Articles published online
|
Jun 21, 2010 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang JJ, Wu HS, Wang L, Tian Y, Zhang JH, Wu HL. Expression and significance of TLR4 and HIF-1α in pancreatic ductal adenocarcinoma. World J Gastroenterol 2010; 16(23): 2881-2888 [PMID: 20556833 DOI: 10.3748/wjg.v16.i23.2881] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i23/2881.htm |
| Number | Citing Articles |
| 1 |
Ashley Mansell, Brendan J. Jenkins. Dangerous liaisons between interleukin-6 cytokine and toll-like receptor families: A potent combination in inflammation and cancer. Cytokine & Growth Factor Reviews 2013; 24(3): 249 doi: 10.1016/j.cytogfr.2013.03.007
|
| 2 |
Elisa Barone, Alda Corrado, Federica Gemignani, Stefano Landi. Environmental risk factors for pancreatic cancer: an update. Archives of Toxicology 2016; 90(11): 2617 doi: 10.1007/s00204-016-1821-9
|
| 3 |
Lina Elsalem, Ahmad A Jum'ah, Mahmoud A Alfaqih, Osama Aloudat. <p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>. Clinical and Experimental Gastroenterology 2020; : 151 doi: 10.2147/CEG.S243337
|
| 4 |
Somaiyeh Malekghasemi, Jafar Majidi, Behzad Baradaran, Leili Aghebati‐Maleki. Prostate cancer cells modulate the differentiation of THP‐1 cells in response to etoposide and TLR agonists treatments. Cell Biology International 2020; 44(10): 2031 doi: 10.1002/cbin.11410
|
| 5 |
Sandeep Rajput, Lisa D. Volk-Draper, Sophia Ran. TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer. Molecular Cancer Therapeutics 2013; 12(8): 1676 doi: 10.1158/1535-7163.MCT-12-1019
|
| 6 |
Zhen Luo, Zhong‐Jie Yi, Zheng‐Lin Ou, Tong Han, Tao Wan, Yong‐Chang Tang, Zhi‐Chao Wang, Fei‐Zhou Huang. RELA/NEAT1/miR‐302a‐3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. Journal of Cellular Physiology 2019; 234(4): 3583 doi: 10.1002/jcp.27039
|
| 7 |
Fabienne Guillaumond, Juan Lucio Iovanna, Sophie Vasseur. Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways. Archives of Biochemistry and Biophysics 2014; 545: 69 doi: 10.1016/j.abb.2013.12.019
|
| 8 |
Hai-ying Fu, Chun Li, Wei Yang, Xiao-dong Gai, Ting Jia, Yan-ming Lei, Yi Li. FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: Implications for tumor progression and escape. Acta Histochemica 2013; 115(2): 151 doi: 10.1016/j.acthis.2012.06.002
|
| 9 |
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. European Journal of Pharmacology 2024; 969: 176451 doi: 10.1016/j.ejphar.2024.176451
|
| 10 |
Shipra Das, Beny Shapiro, Emily A. Vucic, Sandra Vogt, Dafna Bar-Sagi. Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer. Cancer Research 2020; 80(5): 1088 doi: 10.1158/0008-5472.CAN-19-2080
|
| 11 |
Amirhossein Moslemizadeh, Mohammad Hadi Nematollahi, Sedigheh Amiresmaili, Sanaz Faramarz, Elham Jafari, Mohammad Khaksari, Nima Rezaei, Hamideh Bashiri, Reza Kheirandish. Combination therapy with interferon-gamma as a potential therapeutic medicine in rat's glioblastoma: A multi-mechanism evaluation. Life Sciences 2022; 305: 120744 doi: 10.1016/j.lfs.2022.120744
|
| 12 |
Hanlin Yin, Ning Pu, Qiangda Chen, Jicheng Zhang, Guochao Zhao, Xuefeng Xu, Dansong Wang, Tiantao Kuang, Dayong Jin, Wenhui Lou, Wenchuan Wu. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer. Cell Death & Disease 2021; 12(11) doi: 10.1038/s41419-021-04293-4
|
| 13 |
Ann H. Rosendahl, Chen Sun, DeQuan Wu, Roland Andersson. Polysaccharide-K (PSK) increases p21WAF/Cip1 and promotes apoptosis in pancreatic cancer cells. Pancreatology 2012; 12(6): 467 doi: 10.1016/j.pan.2012.09.004
|
| 14 |
Bo Hao, Zhen Chen, Baochen Bi, Miaomei Yu, Shuang Yao, Yuehua Feng, Yang Yu, Lili Pan, Dongmei Di, Guanghua Luo, Xiaoying Zhang. Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis. Oncotarget 2018; 9(16): 13088 doi: 10.18632/oncotarget.24178
|
| 15 |
Bin Zhao, Xiulong Niu, Suhui Huang, Jing Yang, Yiyi Wei, Xiujuan Wang, Junhong Wang, Yue Wang, Xiaoqin Guo, Ulises Urzua. TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-κB/HIF-1α Loop in Human Epithelial Ovarian Cancer. Analytical Cellular Pathology 2022; 2022: 1 doi: 10.1155/2022/4201262
|
| 16 |
Chih‐Cheng Hsiao, Ying‐Hsien Kao, Shun‐Chen Huang, Jiin‐Haur Chuang. Toll‐like receptor‐4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro. Pediatric Blood & Cancer 2013; 60(2): 248 doi: 10.1002/pbc.24211
|
| 17 |
Sara Zanini, Serena Renzi, Antonina R. Limongi, Paolo Bellavite, Francesco Giovinazzo, Giovanna Bermano. A review of lifestyle and environment risk factors for pancreatic cancer. European Journal of Cancer 2021; 145: 53 doi: 10.1016/j.ejca.2020.11.040
|
| 18 |
Sabina Strapcova, Martina Takacova, Lucia Csaderova, Paola Martinelli, Lubomira Lukacikova, Viliam Gal, Juraj Kopacek, Eliska Svastova. Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions. Cancers 2020; 12(8): 2005 doi: 10.3390/cancers12082005
|
| 19 |
Linli Yao, Enci Mary Kan, Jia Lu, Aijun Hao, S Thameem Dheen, Charanjit Kaur, Eng-Ang Ling. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. Journal of Neuroinflammation 2013; 10(1) doi: 10.1186/1742-2094-10-23
|
| 20 |
Anton G. Kutikhin, Arseniy E. Yuzhalin. Genomics of Pattern Recognition Receptors. 2013; : 1 doi: 10.1007/978-3-0348-0688-6_1
|
| 21 |
Sunhwa Kim, Michael Karin. Role of TLR2‐dependent inflammation in metastatic progression. Annals of the New York Academy of Sciences 2011; 1217(1): 191 doi: 10.1111/j.1749-6632.2010.05882.x
|
| 22 |
Wei Ping, Wen-Yang Jiang, Wen-Shu Chen, Wei Sun, Xiang-Ning Fu. Expression and Significance of Hypoxia Inducible Factor-1α and Lysyl Oxidase in Non-small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention 2013; 14(6): 3613 doi: 10.7314/APJCP.2013.14.6.3613
|
| 23 |
Jianhui Liu, Dong Xu, Qingguang Wang, Datong Zheng, Xiuqin Jiang, Lijian Xu. LPS Induced miR-181a Promotes Pancreatic Cancer Cell Migration via Targeting PTEN and MAP2K4. Digestive Diseases and Sciences 2014; 59(7): 1452 doi: 10.1007/s10620-014-3049-y
|
| 24 |
Daniel Delitto, Andrea E. Delitto, Bayli B. DiVita, Kien Pham, Song Han, Emily R. Hartlage, Brittney N. Newby, Michael H. Gerber, Kevin E. Behrns, Lyle L. Moldawer, Ryan M. Thomas, Thomas J. George, Todd M. Brusko, Clayton E. Mathews, Chen Liu, Jose G. Trevino, Steven J. Hughes, Shannon M. Wallet. Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Cancer Research 2017; 77(3): 672 doi: 10.1158/0008-5472.CAN-16-1765
|
| 25 |
Murielle Mimeault, Surinder K. Batra. Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells. Journal of Cellular and Molecular Medicine 2013; 17(1): 30 doi: 10.1111/jcmm.12004
|
| 26 |
Edward J. Kim, Diane M. Simeone. Advances in pancreatic cancer. Current Opinion in Gastroenterology 2011; 27(5): 460 doi: 10.1097/MOG.0b013e328349e31f
|
| 27 |
Matteo Santoni, Kalliopi Andrikou, Valeria Sotte, Alessandro Bittoni, Andrea Lanese, Chiara Pellei, Francesco Piva, Alessandro Conti, Massimo Nabissi, Giorgio Santoni, Stefano Cascinu. Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target. Cancer Treatment Reviews 2015; 41(7): 569 doi: 10.1016/j.ctrv.2015.04.004
|
| 28 |
Miao-Yan Wei, Si Shi, Chen Liang, Qing-Cai Meng, Jie Hua, Yi-Yin Zhang, Jiang Liu, Bo Zhang, Jin Xu, Xian-Jun Yu. The microbiota and microbiome in pancreatic cancer: more influential than expected. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1008-0
|
| 29 |
Yiyi Zhang, Nie Tang, Hui Zhou, Ying Zhu. The role of microbial metabolites in endocrine tumorigenesis: From the mechanistic insights to potential therapeutic biomarkers. Biomedicine & Pharmacotherapy 2024; 172: 116218 doi: 10.1016/j.biopha.2024.116218
|
| 30 |
Mira A Lanki, Hanna E Seppänen, Harri K Mustonen, Camilla Böckelman, Anne T Juuti, Jaana K Hagström, Caj H Haglund. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer. Tumor Biology 2018; 40(9): 101042831880118 doi: 10.1177/1010428318801188
|
| 31 |
Mousami Srivastava, Pankaj Khurana, Ragumani Sugadev. Lung Cancer Signature Biomarkers: tissue specific semantic similarity based clustering of Digital Differential Display (DDD) data. BMC Research Notes 2012; 5(1) doi: 10.1186/1756-0500-5-617
|
| 32 |
Elisa Perez-Moreno, Claudia Oyanadel, Adely de la Peña, Ronny Hernández, Francisca Pérez-Molina, Claudia Metz, Alfonso González, Andrea Soza. Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis. Biological Research 2024; 57(1) doi: 10.1186/s40659-024-00490-5
|
| 33 |
Joni Leppänen, Olli Helminen, Heikki Huhta, Joonas H. Kauppila, Joel Isohookana, Kirsi-Maria Haapasaari, Seppo Parkkila, Juha Saarnio, Petri P. Lehenkari, Tuomo J. Karttunen. Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1432-4
|
| 34 |
Makena J. Binker-Cosen, Daniel Richards, Brenda Oliver, Herbert Y. Gaisano, Marcelo G. Binker, Laura I. Cosen-Binker. Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4/ROS/NF-κB/MMP-9 signaling pathway. Biochemical and Biophysical Research Communications 2017; 484(1): 152 doi: 10.1016/j.bbrc.2017.01.051
|
| 35 |
Sophia Ran, Nihit Bhattarai, Radhika Patel, Lisa Volk-Draper. Translational Studies on Inflammation. 2020; doi: 10.5772/intechopen.85195
|
| 36 |
Lisa A. Ridnour, Robert Y.S. Cheng, Christopher H. Switzer, Julie L. Heinecke, Stefan Ambs, Sharon Glynn, Howard A. Young, Giorgio Trinchieri, David A. Wink. Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment—Poor Prognosis or New Therapeutic Opportunity. Clinical Cancer Research 2013; 19(6): 1340 doi: 10.1158/1078-0432.CCR-12-0408
|
| 37 |
Zhou Chen, Shaofeng Zhang, Shi Dong, Hao Xu, Wence Zhou. Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.844401
|
| 38 |
D. S. Michaud. Role of bacterial infections in pancreatic cancer. Carcinogenesis 2013; 34(10): 2193 doi: 10.1093/carcin/bgt249
|
| 39 |
Tandrima Mitra, Soumya S. Mahapatra, Barnalee Mishra, Venketesh K. Panda, Diksha Malhotra, Anusuya Roychowdhury, Gopal C. Kundu. Hypoxia in Cancer: Significance and Impact on Cancer Therapy. 2023; : 1 doi: 10.1007/978-981-99-0313-9_1
|
| 40 |
Yunliang Sun, Congshan Wu, Jianxia Ma, Yu Yang, Xiaohua Man, Hongyu Wu, Shude Li. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Experimental Cell Research 2016; 347(2): 274 doi: 10.1016/j.yexcr.2016.07.009
|
| 41 |
Long-Yun Ye, Qi Zhang, Xue-Li Bai, Prasoon Pankaj, Qi-Da Hu, Ting-Bo Liang. Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis. Pancreatology 2014; 14(5): 391 doi: 10.1016/j.pan.2014.06.008
|
| 42 |
Dajia Liu, Anne Steins, Remy Klaassen, Amber P. van der Zalm, Roel J. Bennink, Geertjan van Tienhoven, Marc G. Besselink, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven. Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma. Biomedicines 2020; 8(11): 444 doi: 10.3390/biomedicines8110444
|
| 43 |
Xinming Jing, Fengming Yang, Chuchu Shao, Ke Wei, Mengyan Xie, Hua Shen, Yongqian Shu. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1089-9
|
| 44 |
Ki Hyung Kim, Moo Sung Jo, Dong Soo Suh, Man Soo Yoon, Dong Hun Shin, Jeong Hee Lee, Kyung Un Choi. Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-193
|
| 45 |
Zhichao Liu, Hong Fang, William Slikker, Weida Tong. Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases. Trends in Pharmacological Sciences 2016; 37(10): 843 doi: 10.1016/j.tips.2016.06.010
|
| 46 |
Zhou Chen, Defeng Guan, Zhengfeng Wang, Xin Li, Shi Dong, Junjun Huang, Wence Zhou. Microbiota in cancer: molecular mechanisms and therapeutic interventions. MedComm 2023; 4(6) doi: 10.1002/mco2.417
|
| 47 |
Ling Zhou, Lianwen Qi, Lifeng Jiang, Ping Zhou, Jiang Ma, Xiaojun Xu, Ping Li. Antitumor Activity of Gemcitabine Can Be Potentiated in Pancreatic Cancer through Modulation of TLR4/NF-κB signaling by 6-Shogaol. The AAPS Journal 2014; 16(2): 246 doi: 10.1208/s12248-013-9558-3
|
| 48 |
I-Ting Chen, An-Chieh Cheng, Yi-Ting Liu, Chieh Yan, Yi-Chen Cheng, Chiung-Fang Chang, Ping-Hui Tseng. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA. International Journal of Molecular Sciences 2022; 23(15): 8419 doi: 10.3390/ijms23158419
|
| 49 |
Guanglei Fan, Jingli Bo, Renming Wan, Mingya Peng, Yufen Luan, Minbin Deng, Longbao Xu. The Effect of Lentiviral Vector-Mediated RNA Interference Targeting Hypoxia-Inducible Factor 1α on the Uptake of Fluorodeoxyglucose (18F) in the Human Pancreatic Cancer Cell Line, Patu8988. Cancer Biotherapy and Radiopharmaceuticals 2015; 30(4): 160 doi: 10.1089/cbr.2014.1700
|
| 50 |
Anton G. Kutikhin. Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. Human Immunology 2011; 72(11): 1095 doi: 10.1016/j.humimm.2011.07.307
|
| 51 |
Lisa Volk-Draper, Kelly Hall, Caitlin Griggs, Sandeep Rajput, Pascaline Kohio, David DeNardo, Sophia Ran. Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner. Cancer Research 2014; 74(19): 5421 doi: 10.1158/0008-5472.CAN-14-0067
|
| 52 |
Ga-Bin Park, Jee-Yeong Jeong, Daejin Kim. GLUT5 regulation by AKT1/3-miR-125b-5p downregulation induces migratory activity and drug resistance in TLR-modified colorectal cancer cells. Carcinogenesis 2020; 41(10): 1329 doi: 10.1093/carcin/bgaa074
|
| 53 |
Anna Maria Nurmi, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund, Girijesh Kumar Patel. The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy. PLOS ONE 2022; 17(5): e0267792 doi: 10.1371/journal.pone.0267792
|
| 54 |
E. Marks, C. Naudin, G. Nolan, B.J. Goggins, G. Burns, S.W. Mateer, J.K. Latimore, K. Minahan, M. Plank, P.S. Foster, R. Callister, M. Veysey, M.M. Walker, N.J. Talley, G. Radford-Smith, S. Keely. Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation. Mucosal Immunology 2017; 10(5): 1224 doi: 10.1038/mi.2016.135
|
| 55 |
Xin Wei, Chunlei Mei, Xixi Li, Yingjun Xie. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021; 50(2): 119 doi: 10.1097/MPA.0000000000001744
|
| 56 |
Tongshuo Zhang, Jing Yang, Yang Sun, Jiangnan Song, Dandan Gao, Suhui Huang, Aibo Pang, Jianhui Zhang, Junhong Wang, Yue Wang, Yanqiu Li, Silvia Cantara. Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1α Feedback Loop. Analytical Cellular Pathology 2023; 2023: 1 doi: 10.1155/2023/8334881
|
| 57 |
Prasanna Srinivasan Ramalingam, Sivakumar Arumugam. Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS. Medical Oncology 2023; 40(10) doi: 10.1007/s12032-023-02160-0
|
| 58 |
Mitsuru Sugimoto, Kazumichi Abe, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Ko Watanabe, Jun Nakamura, Hitomi Kikuchi, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Takuto Hikichi, Hiromasa Ohira. Dysbiosis of the duodenal microbiota as a diagnostic marker for pancreaticobiliary cancer. World Journal of Gastrointestinal Oncology 2021; 13(12): 2088-2100 doi: 10.4251/wjgo.v13.i12.2088
|
| 59 |
Mahesh Chandra Patra, Masaud Shah, Sangdun Choi. Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases. Seminars in Cancer Biology 2020; 64: 61 doi: 10.1016/j.semcancer.2019.05.002
|
| 60 |
Goutam Chowdhury, Dharanidharan Ramamurthy. Human Microbiome. 2022; : 73 doi: 10.1007/978-981-16-7672-7_4
|
| 61 |
Joni Leppänen, Olli Helminen, Heikki Huhta, Joonas H. Kauppila, Joel Isohookana, Kirsi-Maria Haapasaari, Petri Lehenkari, Juha Saarnio, Tuomo J. Karttunen. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Archiv 2017; 470(4): 401 doi: 10.1007/s00428-017-2087-1
|
| 62 |
Katharina Beyer, Lars Ivo Partecke, Felicitas Roetz, Herbert Fluhr, Frank Ulrich Weiss, Claus-Dieter Heidecke, Wolfram von Bernstorff. LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0139-4
|
| 63 |
Jaroslaw Daniluk, Urszula Daniluk, Pawel Rogalski, Andrzej Dabrowski, Agnieszka Swidnicka-Siergiejko. Microbiome—Friend or Foe of Pancreatic Cancer?. Journal of Clinical Medicine 2021; 10(23): 5624 doi: 10.3390/jcm10235624
|
| 64 |
Marion Dajon, Kristina Iribarren, Isabelle Cremer. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword. Immunobiology 2017; 222(1): 89 doi: 10.1016/j.imbio.2016.06.009
|
| 65 |
Shaherin Basith, Balachandran Manavalan, Tae Hyeon Yoo, Sang Geon Kim, Sangdun Choi. Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense. Archives of Pharmacal Research 2012; 35(8): 1297 doi: 10.1007/s12272-012-0802-7
|
| 66 |
Qian Zhang, Jun Dan, Shuang Meng, Yingjie Li, Jing Li. TLR4 inhibited autophagy by modulating PI3K/AKT/mTOR signaling pathway in Gastric cancer cell lines. Gene 2023; 876: 147520 doi: 10.1016/j.gene.2023.147520
|
| 67 |
Shrabon Hasnat, Roosa Hujanen, Bright I. Nwaru, Tuula Salo, Abdelhakim Salem. The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 2020; 21(19): 7255 doi: 10.3390/ijms21197255
|
| 68 |
Huan Yang, Bo Wang, Tao Wang, Longjiang Xu, Chunyan He, Huiyan Wen, Jie Yan, Honghong Su, Xueming Zhu, Kottarappat N. Dileepan. Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis. PLoS ONE 2014; 9(10): e109980 doi: 10.1371/journal.pone.0109980
|
| 69 |
Kaka Renaldi, Marcellus Simadibrata, Nur Rahadiani, Diah Rini Handjari, Alida Roswita Harahap, Kuntjoro Harimurti, Nasrul Zubir, Lianda Siregar, Imelda Maria Loho, Evlina Suzanna, Bonita Prawirodihardjo, Heriawaty Hidajat, Budi Widodo, Alphania Rahniayu, Renaningtyas Tambun, Andy William, Dadang Makmun. The Expressions of NF−κB, COX−2, Sp1, and c−Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival. Pathophysiology 2023; 30(2): 92 doi: 10.3390/pathophysiology30020009
|